Skip to main content
. 2020 Mar 6;11:93. doi: 10.3389/fendo.2020.00093

Figure 5.

Figure 5

Candidate drug repurposing based on dysregulated lnc-FFLs associated with GDM. (A) The thyroid hormone pathway, and enriched target genes of miRNAs in dysregulated lnc-FFLs associated with GDM. (B) Drug-related dysregulated lnc-FFL networks. The square represents drugs and the circle represents genes, lncRNAs, and miRNAs. (C) Pie chart showing the percent of anti-inflammatory and hormonal drugs. (D) Candidate drug repurposing of the ESPRA-related lnc-FFL.